Glycomet Trio 2/0.3 Tab

Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Uses of Glycomet Trio 2/0.3 Tab

Type 2 diabetes mellitus (adult) when blood sugar is not adequately controlled with diet/exercise and single or dual therapy; helps control post‑meal and fasting blood glucose

• •Lowers fasting blood glucose
• •Reduces post‑meal glucose spikes
• •Improves HbA1c control
• •Enhances insulin sensitivity
• •Provides multi‑mechanism diabetes control in one tablet

How it works

Metformin reduces glucose production in the liver and improves insulin sensitivity. Glimepiride stimulates the pancreas to release insulin. Voglibose delays carbohydrate absorption in the gut by inhibiting alpha‑glucosidase enzymes, reducing post‑meal glucose spikes.

Directions for use

Oral tablet. Take exactly as prescribed, usually once daily with food (typically with the first main meal); swallow whole if prolonged‑release—do not crush/chew. Follow diet and exercise advice and monitor blood glucose regularly.

Side effects

Common side effects of Glycomet Trio 2/0.3 Tab may include:

• •Hypoglycaemia
• •nausea
• •diarrhoea
• •abdominal pain
• •flatulence